Telomere Therapeutics
About:
Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Website: https://telomere-tx.com/
Top Investors: Invivo Capital Partners, CDTI
Description:
Telomere Therapeutics creates gene therapy based on telomerase gene expression for the treatment of age-related diseases like idiopathic pulmonary fibrosis, aplastic anemia, or dyskeratosis congenita.
Total Funding Amount:
3.39M EUR
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2020-11-01
Founders:
Fàtima Bosch, Maria Blasco, Paula Martínez
Number of Employees:
1-10
Last Funding Date:
2021-05-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai